Enfusion, Inc. (NYSE:ENFN) Sees Significant Decrease in Short Interest

Enfusion, Inc. (NYSE:ENFN) saw a large decrease in short interest in October. As of October 31st, there was short interest totalling 1,180,000 shares, a decrease of 22.4% from the October 15th total of 1,520,000 shares. Currently, 2.4% of the shares of the stock are sold short. Based on an average daily trading volume, of 381,300 shares, the days-to-cover ratio is currently 3.1 days.

Enfusion Stock Performance

NYSE:ENFN opened at $9.79 on Friday. The company has a 50-day moving average of $9.00 and a 200-day moving average of $8.86. Enfusion has a 52 week low of $7.52 and a 52 week high of $10.45. The company has a market capitalization of $1.26 billion, a price-to-earnings ratio of 244.81, a PEG ratio of 3.66 and a beta of 0.93.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ENFN. Centiva Capital LP grew its stake in shares of Enfusion by 5.0% in the 3rd quarter. Centiva Capital LP now owns 25,596 shares of the company’s stock valued at $243,000 after purchasing an additional 1,227 shares during the period. Harbor Capital Advisors Inc. boosted its stake in Enfusion by 12.4% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 11,887 shares of the company’s stock valued at $113,000 after buying an additional 1,315 shares in the last quarter. Azora Capital LP grew its position in Enfusion by 6.8% in the third quarter. Azora Capital LP now owns 29,827 shares of the company’s stock valued at $283,000 after acquiring an additional 1,890 shares during the period. 272 Capital LP raised its stake in Enfusion by 1.5% during the second quarter. 272 Capital LP now owns 139,180 shares of the company’s stock worth $1,186,000 after acquiring an additional 2,000 shares in the last quarter. Finally, California State Teachers Retirement System lifted its holdings in shares of Enfusion by 11.0% during the first quarter. California State Teachers Retirement System now owns 36,002 shares of the company’s stock valued at $333,000 after acquiring an additional 3,556 shares during the period. Institutional investors own 81.05% of the company’s stock.

Enfusion Company Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.